• 제목/요약/키워드: Ground glass opacity

검색결과 79건 처리시간 0.029초

폐포단백증 1예 (A Case of Pulmonary Alveolar Proteinosis)

  • 우대형;박정은;류영하;김현정;신경철;정진홍;이관호
    • Journal of Yeungnam Medical Science
    • /
    • 제27권1호
    • /
    • pp.57-62
    • /
    • 2010
  • Pulmonary alveolar proteinosis (PAP) is a rare disorder that's characterized by accumulation of surfactant components in the alveolar space. Idiopathic PAP is recognized as an autoimmune disease that's due to impaired alveolar macrophage function and this caused by autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF). We report here a case of pulmonary alveolar proteinosis that was deemed interstitial lung disease at the initial diagnosis. A 61-year-old man presented with intermittent blood tinged sputum and dyspnea on exertion. The man was a painter for 30 years and he had a 10 pack-years smoking history. Chest computerized tomography (CT) revealed multifocal ground-glass opacity with interstitial thickening at both lungs. His pulmonary function tests and methacholine test revealed non specific results. He was diagnosed with interstitial lung disease on the basis of the chest CT finding and occupational history. However, seven months later, his symptoms progressed. Follow-up chest CT was performed. Wedge resection via video-assisted thoracoscopic surgery (the anterior basal segment of the left lower lobe) was done. Microscopic examination showed large groups of alveoli with excessive amounts of surfactant and a complex mixture of protein and lipid (fat) molecules. Finally, he was diagnosed as having pulmonary alveolar proteinosis.

  • PDF

전립선 암에서 Bicalutamide 사용으로 생긴 간질성 폐질환 1예 (Bicalutamide-induced Interstitial Lung Disease)

  • 김양균;김이형;이재진;최천웅;유지홍;박명재;강홍모
    • Tuberculosis and Respiratory Diseases
    • /
    • 제68권4호
    • /
    • pp.226-230
    • /
    • 2010
  • Androgen deprivation therapy, which is the standard treatment for metastatic prostate cancer, includes nonsteroidal antiandrogenic drugs, such as flutamide, nilutamide and bicalutamide. Of them, bicalutamide rarely induces interstitial pneumonia. We report a case of bicalutamide-induced interstitial pneumonia. A 68-year old male diagnosed with prostate cancer and multiple bone metastases presented with dry cough and low grade fever for 3 days. He had taken bicalutamide (50 mg/day) for 13 months. High resolution computed tomography revealed ground glass opacity in his right upper lung. The laboratory studies showed no eosinophilia in the serum and bronchoalveolar lavage fluid. Despite the use of antimicrobial agents for 2 weeks, the extent of the lung lesions increased to the left upper and right lower lung. He had no environmental exposure, collagen vascular disease and microbiological causes. Under the suspicion of bicalutamide-induced interstitial pneumonia, bicalutamide was stopped and prednisolone (1 mg/kg/ day) was initiated. The symptoms and radiologic abnormalities were resolved with residual minimal fibrosis.

폐섬유화를 동반한 재발성 박리성 간질성 폐렴 (Recurrent Desquamative Interstitial Pneumonia with Fibrotic Lung Disease)

  • 김원진;최정희;박용범;조성우;남은숙;모은경
    • Tuberculosis and Respiratory Diseases
    • /
    • 제65권4호
    • /
    • pp.328-333
    • /
    • 2008
  • 박리성 간질성 폐렴은 흡연가에 호발하는 비교적 드문 미만성 간질성 폐질환이다. 박리성 간질성 폐렴은 치료에 대한 반응과 예후가 좋은 질환이나, 재발하는 경우가 있고 치료기간이 명확히 정해져 있지 않으며, 심한 섬유화가 동반되는 경우는 드문 질환이다. 저자들은 흉부 전산화단층 촬영에서 견인성 기관지확장증과 초기의 벌집모양 폐 소견과 함께 미만성 간유리혼탁화를 보이는 환자에서 흉강경하 폐 조직 검사로 박리성 간질성 폐렴을 진단하였고, 치료 종결 후 재발한 박리성 간질성 폐렴을 경험하였기에 이를 보고하는 바이다.

Bleomycin 투여 후 발생한 폐쇄세기관지기질화폐렴 (A Case of the Bleomycin-Induced Bronchiolitis Obliterans Organizing Pneumonia)

  • 한창훈;문진욱;장제현;최병욱;신동환;김세규;장준;김성규;김영삼
    • Tuberculosis and Respiratory Diseases
    • /
    • 제55권3호
    • /
    • pp.311-316
    • /
    • 2003
  • 저자들은 폐전이가 동반된 고환암 환자에서 bleomycin을 포함한 항암화학요법제 투여 후 발열과 기침을 호소하는 환자에서 발생한 약물 유발성 폐독성으로 인한 폐쇄세기관지기질화폐렴 양상의 폐손상을 문헌 고찰과 함께 보고하는 바이다.

Gemcitabine에 의한 약물 유발성 간질성 폐렴 1예 (A Case of Drug Induced Interstitial Pneumonitis by Gemcitabine)

  • 이성순;함초롬;진재용;이혜란;김수영;김미영;이현경;이혁표;염호기;최수전
    • Tuberculosis and Respiratory Diseases
    • /
    • 제56권3호
    • /
    • pp.315-320
    • /
    • 2004
  • Gemcitabine은 최근 사용이 증가되고 있는 항암제로서 호흡기 부작용이 흔히 발생하나 대부분 일시적이고 자연 관해된다. 하지만 드물게 gemcitabine에 의한 심각한 폐 독성이 발생할 수 있으며, 이는 조기 진단 및 치료가 중요하다. 저자들은 gemcitabine 치료 후 발생한 중증 약물 유발성 간질성 폐렴 환자에서 스테로이드 치료 후 호전된 증례를 경험하였기에 보고하는 바이다.

Outcome of Limited Resection for Lung Cancer

  • Cho, Jeong-Su;Jheon, Sang-Hoon;Park, Sung-Joon;Sung, Sook-Whan;Lee, Choon-Taek
    • Journal of Chest Surgery
    • /
    • 제44권1호
    • /
    • pp.51-57
    • /
    • 2011
  • Background: Up to now, lobectomy, bilobectomy and pneumonectomy combined with extensive lymph node dissection have been regarded as the standard procedures for non-small cell lung cancer (NSCLC). In high-risk patients, however, limited resection (LR) has been attempted as a salvage procedure, and, recently, indication for LR has been extended to selected cases with early-stage NSCLC. Material and Methods: Among the 773 patients who underwent surgical procedures for NSCLC in Seoul National University Bundang Hospital from May 2003 to December 2008, 43 patients received LR. Medical records of these patients were retrospectively reviewed. Results: Mean age at operation was $66.0{\pm}12.4$ years, and there were 30 males. Twenty-five patients underwent conservative limited resection (CLR) and 18 underwent intentional limited resection (ILR). Indications for CLR were multiple primary lung cancer in 9 (9/25, 36%) and severe concomitant diseases in 5 (5/25, 20%). Of these, 6 patients underwent segmentectomy and 19 received wedge resection. During the follow-up period of $28.0{\pm}17.8$ months, 15 patient developed recurrent lung cancer. ILR was selectively performed in lesions almost purely composed of ground glass opacity (${\geq}$95%), or in small solid lesions (${\leq}$2 cm). Of these, 11 patients underwent segmentectomy and 7 underwent wedge resection. During the follow-up period of $31.7{\pm}11.6$ months, no patient developed recurrence. Conclusion: Intermediate-term outcome of LR for early-stage lung cancer is comparable to that of standard operation. For the delineation of the indications and appropriate surgical techniques for LR, prospective randomized multi-institutional study may be expedient.

Comparison of clinical features and laboratory findings of coronavirus disease 2019 and influenza A and B infections in children: a single-center study

  • Siddiqui, Meraj;Gultekingil, Ayse;Bakirci, Oguz;Uslu, Nihal;Baskin, Esra
    • Clinical and Experimental Pediatrics
    • /
    • 제64권7호
    • /
    • pp.364-369
    • /
    • 2021
  • Background: As the coronavirus disease 2019 (COVID-19) outbreak continues to evolve, it is crucially important for pediatricians to be aware of the differences in demographic and clinical features between COVID-19 and influenza A and B infections. Purpose: This study analyzed and compared the clinical features and laboratory findings of COVID-19 and influenza A and B infections in children. Methods: This retrospective study evaluated the medical data of 206 pediatric COVID-19 and 411 pediatric seasonal influenza A or B patients. Results: COVID-19 patients were older than seasonal influenza patients (median [interquartile range], 7.75 [2-14] years vs. 4 [2-6] years). The frequency of fever and cough in COVID-19 patients was lower than that of seasonal influenza patients (80.6% vs. 94.4%, P<0.001 and 22.8 % vs. 71.5%, P<0.001, respectively). Ageusia (4.9%) and anosmia (3.4%) were present in only COVID-19 patients. Leukopenia, lymphopenia, and thrombocytopenia were encountered more frequently in influenza patients than in COVID-19 patients (22.1% vs. 8.5%, P=0.029; 17.6% vs. 5.6%, P=0.013; and 13.2% vs. 5.6%, P=0.048, respectively). Both groups showed significantly elevated monocyte levels in the complete blood count (70.4% vs. 69.9%, P=0.511). Major chest x-ray findings in COVID-19 patients included mild diffuse ground-glass opacity and right lower lobe infiltrates. There were no statistically significant intergroup differences in hospitalization or mortality rates; however, the intensive care unit admission rate was higher among COVID-19 patients (2.4% vs. 0.5%, P=0.045). Conclusion: In this study, pediatric COVID-19 patients showed a wide range of clinical presentations ranging from asymptomatic/mild to severe illness. We found no intergroup differences in hospitalization rates, oxygen requirements, or hospital length of stay; however, the intensive care unit admission rate was higher among COVID-19 patients.

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia

  • Lee, Jongmin;Kim, Yong Hyun;Kang, Ji Young;Jegal, Yangjin;Park, So Young;Korean Interstitial Lung Diseases Study Group
    • Tuberculosis and Respiratory Diseases
    • /
    • 제82권4호
    • /
    • pp.277-284
    • /
    • 2019
  • Idiopathic nonspecific interstitial pneumonia (NSIP) is one of the varieties of idiopathic interstitial pneumonias. Diagnosis of idiopathic NSIP can be done via multidisciplinary approach in which the clinical, radiologic, and pathologic findings were discussed together and exclude other causes. Clinical manifestations include subacute or chronic dyspnea and cough that last an average of 6 months, most of which occur in non-smoking, middle-aged women. The common findings in thoracic high-resolution computed tomography in NSIP are bilateral reticular opacities, traction bronchiectasis, reduced volume of the lobes, and ground-glass opacity in the lower lungs. These lesions can involve diffuse bilateral lungs or subpleural area. Unlike usual interstitial pneumonia, honeycombing is sparse or absent. Pathology shows diffuse interstitial inflammation and fibrosis which are temporally homogeneous, namely NSIP pattern. Idiopathic NSIP is usually treated with steroid only or combination with immunosuppressive agents such as azathioprine, cyclophosphamide, cyclosporine, and mycophenolate mofetil. Prognosis of idiopathic NSIP is better than idiopathic pulmonary fibrosis. Many studies have reported a 5-year survival rate of more than 70%.

Immunoglobulin G4 관련 폐 질환의 질병 경과에 따른 순차적 CT 소견: 증례 보고 (Sequential CT Findings in Two Cases of Immunoglobulin G4-Related Lung Disease: Focused on Disease Progression)

  • 이동규;함수연
    • 대한영상의학회지
    • /
    • 제79권5호
    • /
    • pp.276-281
    • /
    • 2018
  • 면역글로불린 G4 (Immunoglobulin G4; 이하 IgG4) 관련 폐 질환은 지난 몇 년간 활발하게 기술되어 온 질환이다. IgG4 관련 폐 질환의 영상의학적 소견은 환자마다 다양하게 알려져 있으나, 질병의 진행에 따른 다양한 영상 소견들을 장기 추적한 연구는 보고되지 않았다. 본 증례 보고에서는 비교적 장기간의 추적을 시행한 2예를 통해, IgG4 관련 폐 질환의 다양한 초기 및 후기 컴퓨터단층촬영 소견들을 고찰하였다. 비교적 초기 CT에서 보였던 결절성 혹은 미만성 간유리음영과 달리, 벌집모양음영이나 견인성 기관지확장증은 후기 소견들로 생각되었다. 고형 결절들은 초기 및 후기에서 모두 보였으나, 새로운 결절의 발생 혹은 기존 결절들의 크기 증가가 질병이 진행함에 따라 나타났다. 소엽간 중격 비후와 종격동 및 폐문 림프절 비대는 질병의 후기에서도 지속적으로 관찰되었다. 이는 IgG4 관련 폐 질환의 정확하고 시기적절한 진단에 도움이 될 것으로 기대된다.

Prognostic Analysis of Stage I Non-Small Cell Lung Cancer Abutting Adjacent Structures on Preoperative Computed Tomography

  • Soohwan Choi;Sun Kyun Ro;Seok Whan Moon
    • Journal of Chest Surgery
    • /
    • 제57권2호
    • /
    • pp.136-144
    • /
    • 2024
  • Background: Early non-small cell lung cancer (NSCLC) that abuts adjacent structures requires careful evaluation due to its potential impact on postoperative outcomes and prognosis. We examined stage I NSCLC with invasion into adjacent structures, focusing on the prognostic implications after curative surgical resection. Methods: We retrospectively analyzed the records of 796 patients who underwent curative surgical resection for pathologic stage IA/IB NSCLC (i.e., visceral pleural invasion only) at a single center from 2008 to 2017. Patients were classified based on tumor abutment and then reclassified by the presence of visceral pleural invasion. Clinical characteristics, pathological features, and survival rates were compared. Results: The study included 181 patients with abutting NSCLC (22.7% of all participants) and 615 with non-abutting tumors (77.3%). Those with tumor abutment exhibited higher rates of non-adenocarcinoma (26.5% vs. 9.9%, p<0.01) and visceral/lymphatic/vascular invasion (30.4%/33.1%/12.7% vs. 8.5%/22.4%/5.7%, respectively; p<0.01) compared to those without abutment. Multivariable analysis identified lymphatic invasion and male sex as risk factors for overall survival (OS) and disease-free survival (DFS) in stage I NSCLC measuring 3 cm or smaller. Age, smoking history, vascular invasion, and recurrence emerged as risk factors for OS, whereas the presence of non-pure ground-glass opacity was a risk factor for DFS. Conclusion: NSCLC lesions 3 cm or smaller that abut adjacent structures present higher rates of various risk factors than non-abutting lesions, necessitating evaluation of tumor invasion into adjacent structures and lymph node metastasis. In isolation, however, the presence of tumor abutment without visceral pleural invasion does not constitute a risk factor.